1Elders MJ. The increasing impact of arthritis on public health [J]. J Rheumatol Suppl,2000 ,60 :6-8.
2Hayami T, Pickarski M, Wesolowski GA, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior eruciate ligament transection model [ J ]. Arthritis Rheum,2004,50 : 1193-1206.
3Cranney A,Tugwen P,Zytaruk N,et al. Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis [ J ]. Endocr Rev, 2002,23 : 540 -551.
4Hamerman D. The biology of osteoarthritis [ J ]. N Engl J Med, 1989, 320 : 1322-1330.
5Franchimont P, Bassleer C, Henrotin Y, et al. Effects of human and salmon calcitonin on human articular ehondrocytescuhivated in clusters [ J ]. J Clin Endoerinol Metab, 1989,69 : 259-266.
7Marshall KW,Chan AD. Bilateral canine model of osteoarthritis[ J ]. J Rheumatol, 1996,23:344-350.
8Hajjaji H, Williams JM, Devogelaer JP, et al. Treatment with ealeitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis[J]. Osteoarthfitis Cartilage ,2004,12:904-911.
9Austin LA, Heath H III. Calcitonin: physiology and pathophysiology [J]. N Engl J Med,1981,304 :269-278.
10Defios LJ, First BP. Calcitonin as a drug [ J ]. Ann Intern Ged, 1981, 95 : 192-197.
3Weiss RE,Singer FR,Gorn AH,et al. Calcitonin stimulates bone formation when administered prior to initiation of osteogenesis [ J ]. J Clinlnvest, 1981,68:815 - 818.
4Badurski JE. Schwamm W Popko J. et al. Chondroprotective action of salmon calcitonin in experimental arthropathies[ J ]. Calcif Tissue Int,1991,49:27 - 34.
5Manicourt DH, Altman RD, Williams JM,et al. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stage of canine experimental osteoarthritis and significiantly reduces the severity of the cartilage lesions [ J ]. Arthritis Rheum,1999,42 : 1159 - 1167.
6Makin HJ,Dorfrnan H. Biochemical andmetabolic abnormaliaties in caticular cartilage from osteoarthritisc human hips [ J ]. Surg (Am) ,.1971,53:523 -537.
7Baxter E. Fraser JR, Hams GS, et al. Stimulation of glycosaminoglycans synthesis bv thyrocalcitonin preparations [ J ]. Med J. Aust,1968,1:216 -217.
8Bassleer C, Henrotin Y, Bassleer R,et al. Three-dimensional culture model for studying human chondrocyte functions[ M ]. Methods used in research for cartilaginous tissues, Israel, 1989.
9Brandt KD,Braunstein EM,Visco DM,et al,Anterior(crania) cruciate ligament transectionin the dog:abona fide model of osteoarthritis,not merely of cartilage in jury and repair[J].J Rheumato,1991,18:4362 -4461.
10Bagger YU Z,Laszlo B,et al.Oral salmon calcitonin induced suppression of urinary collagen type Ⅱ degradation in postmenopausal women:a new potential treatment of osteoarthritis[J].Bone,2005,37:425-430.
8Nelson KK, Melendez JA. Mitochondrial redox control of matrix metalloproteinases[J]. Free Radic Biol Med , 2004, 37:768-784.
9Massieotte F, Lajeunesse D, Benderdour M ,et al. Can altered production of interleukin - 1 beta, interleukin -6, transforming growth factor -beta and prostaglandin E (2) by isolated human subchondral osteoblasts identify two subgroups ofosteoarthritie patiants[J]. Osteoarthritis Cartilage, 2002, 10:491 - 500.
10Paredes Y, Massicotte F, Pelletier JP, et al. Study of the role of leukotriene B (4) in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5 - lipoxygenase inhibition [ J ]. Arthritis Rheum, 2002, 46 : 1804 - 1812.
